Introduction to adenosine receptors as therapeutic targets.
about
The CD39-adenosinergic axis in the pathogenesis of immune and nonimmune diabetesWinning a Won Game: Caffeine Panacea for Obesity SyndemicEquilibrative nucleoside transporters-A review.Adenosine amine congener as a cochlear rescue agent.Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists.The use of G-protein coupled receptor models in lead optimization.Guanosine regulates adenosine levels in the kidneyStructure based prediction of subtype-selectivity for adenosine receptor antagonistsInternational Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an updateAdverse and protective influences of adenosine on the newborn and embryo: implications for preterm white matter injury and embryo protectionHostile, hypoxia-A2-adenosinergic tumor biology as the next barrier to overcome for tumor immunologistsRegulation of cardiovascular development by adenosine and adenosine-mediated embryo protection.Optimization of adenosine 5'-carboxamide derivatives as adenosine receptor agonists using structure-based ligand design and fragment screening.Extracellular guanosine regulates extracellular adenosine levels.Toward a classification of medications for sleep and circadian rhythm disorders.Mesenchymal stem cell exosome ameliorates reperfusion injury through proteomic complementation.Allosteric interactions at adenosine A(1) and A(3) receptors: new insights into the role of small molecules and receptor dimerization.Inosine strongly enhances proliferation of human C32 melanoma cells through PLC-PKC-MEK1/2-ERK1/2 and PI3K pathways.Long-term consequences of disrupting adenosine signaling during embryonic development.Hydration Site Thermodynamics Explain SARs for Triazolylpurines Analogues Binding to the A2A ReceptorInhibition of small HA fragment activity and stimulation of A2A adenosine receptor pathway limit apoptosis and reduce cartilage damage in experimental arthritis.Regulation of Cell Proliferation by the Guanosine-Adenosine Mechanism: Role of Adenosine ReceptorsHighly selective A(1) -adenosine-agonist (2-chloro-N6-cyclopentyladenosine) and reduction of flap necrosis in adipocutaneous flaps in rats.Caffeine affects HFD-induced hepatic steatosis by multifactorial intervention.Characterisation of endogenous A2A and A2B receptor-mediated cyclic AMP responses in HEK 293 cells using the GloSensor™ biosensor: Evidence for an allosteric mechanism of action for the A2B-selective antagonist PSB 603.CD39-adenosinergic axis in renal pathophysiology and therapeutics.The Cholangiocyte Adenosine-IL-6 Axis Regulates Survival During Biliary Cirrhosis.Caffeine Protects Against Anticonvulsant-Induced Neurotoxicity in the Developing Rat Brain.Effect of decaffeinated coffee on function and nucleotide metabolism in kidney.Design and Rationale for comParison Between ticagreLor and clopidogrEl on mIcrocirculation in Patients with Acute cOronary Syndrome Undergoing Percutaneous Coronary Intervention (PLEIO) Trial.A1 not A2A adenosine receptors play a role in cortical epileptic afterdischarges in immature rats.Effects of caffeine on neuronal apoptosis in neonatal hypoxic-ischemic brain injury.Ilex paraguariensis modulates fat metabolism in Caenorhabditis elegans through purinergic system (ADOR-1) and nuclear hormone receptor (NHR-49) pathways
P2860
Q26825668-89D32735-AD18-4292-A2ED-032A1A8C87A6Q29540785-D514E88D-B3F8-4E20-B06A-F20B5B0D000CQ30244329-2FA7BCB9-4758-4B68-B8CF-E253159DC578Q30430524-5DCE8AA0-6480-41E2-B3E6-F64836702789Q30435017-A7F5DFCA-33AE-40D3-AA39-99063521E83EQ33893103-1639F2BF-9C35-4CFC-BEB4-91EF36F64D32Q33902942-7D41EA2F-2C67-4653-A1B4-163A65D513CEQ34306247-CE05055C-AC9F-4A49-A405-8A6EE7C86A7AQ34701303-BB019388-E8B9-4BB8-9B4C-C9AC97EEE81BQ34999682-3946E238-95F9-4031-8177-ADFB4C0D7223Q35090797-4437341E-C0E3-4289-A170-7C75C8501CBCQ35836829-89D336A6-8AE7-4A5A-89AA-1BDDAB546FD0Q36343219-6B9D6955-0A83-4D69-963E-3422DB4CC16FQ36699593-774D82A2-929E-4CF2-AF43-56D9A5B2F3DAQ37391200-9394829C-DFA2-4D84-930E-F6F370E23A6BQ38087991-8F0ACCA9-0107-4F1E-A084-92A526F84177Q38136285-6872AA59-D2C3-47C7-8609-CD6BC2A5E55DQ38987177-0ACAB3AC-CFB0-4D7D-A6A1-4DF6075585EBQ39137219-D01291D3-9D65-4BEE-878B-68DAEA51B778Q39159119-48B3F1E7-1529-49F8-823F-32096E7AC130Q41685843-FC77A988-0C84-4614-880F-9BBD9FD15B9FQ41924569-84959618-FD8E-4685-A472-0D81789DB632Q43755499-FA4C3D54-B057-478F-AC33-6E615593D0E4Q47284604-FB1CB802-256B-4F79-9E4E-6474D43EF724Q47437537-7245FC97-6FE9-4CAE-B82F-BAE6D271DFE5Q47655859-988F2A0F-47CA-4312-9026-3092E8093B38Q47821845-2B357634-E628-4D98-912B-449B4442036BQ48227666-7236F051-99DA-4BCE-B599-B8B3B901A9EFQ49202553-6A490A12-F2A6-4B93-A914-761C5C0441C8Q49980042-C880E943-C9AB-435D-9C93-90725CF72650Q50662920-D72326E8-CC8A-440A-812C-842806E92F41Q53074585-04FD5A2E-969D-4631-B101-3B8E516B99EAQ58699200-44E10B6F-D702-49D3-9BE9-35DF02422DB4
P2860
Introduction to adenosine receptors as therapeutic targets.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Introduction to adenosine receptors as therapeutic targets.
@ast
Introduction to adenosine receptors as therapeutic targets.
@en
type
label
Introduction to adenosine receptors as therapeutic targets.
@ast
Introduction to adenosine receptors as therapeutic targets.
@en
prefLabel
Introduction to adenosine receptors as therapeutic targets.
@ast
Introduction to adenosine receptors as therapeutic targets.
@en
P2860
P1476
Introduction to adenosine receptors as therapeutic targets.
@en
P2093
Kenneth A Jacobson
P2860
P356
10.1007/978-3-540-89615-9_1
P577
2009-01-01T00:00:00Z